ID: ALA1288796

Max Phase: Preclinical

Molecular Formula: C14H15ClN2

Molecular Weight: 246.74

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Clc1ccc2c(NC3CCCC3)ccnc2c1

Standard InChI:  InChI=1S/C14H15ClN2/c15-10-5-6-12-13(7-8-16-14(12)9-10)17-11-3-1-2-4-11/h5-9,11H,1-4H2,(H,16,17)

Standard InChI Key:  ZVSVCLNPECDDKD-UHFFFAOYSA-N

Associated Targets(non-human)

Major prion protein 73 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 246.74Molecular Weight (Monoisotopic): 246.0924AlogP: 4.24#Rotatable Bonds: 2
Polar Surface Area: 24.92Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.28CX LogP: 3.56CX LogD: 3.33
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.86Np Likeness Score: -1.18

References

1. Macedo B, Kaschula CH, Hunter R, Chaves JA, van der Merwe JD, Silva JL, Egan TJ, Cordeiro Y..  (2010)  Synthesis and anti-prion activity evaluation of aminoquinoline analogues.,  45  (11): [PMID:20797807] [10.1016/j.ejmech.2010.07.054]

Source